Cloud Technology Help us Provide Personalized Health Care Services

Today we announce that CellMark partners with Health Invest Finland, a Finnish startup company focusing on smart device technology to improve health care. CellMark’s expertise in medical device distribution, logistics and sales support will enable My+Care™ to gain traction with healthcare facilities around the world. The partnership will cover Asia, Europe, Africa, N America, S America and the Middle East.

Health Invest has developed an innovative health 24/7 service solution in the form of a wristband, My+Care™. The band makes health care mobile and makes it easier to predict and anticipate patients’ needs. It registers a condition or behavior instantly. For instance, if we move or fall the data is analyzed in an app in real time, and help can be sent instantaneously.

We are heading in a direction where there are more people in need of care than there are resources. The My+Care™ technology is developed to be used in the health care sector, for public as well as private establishments. Both patients and providers benefit from this new cloud-based technology which will make health care happen promptly and secure personalized care. Consequently it may save or even extend human lives. With this kind of cloud based technology solutions, we can envision a future of health care that provides us with dignity, security and a valuable way of life while keeping the sense of independency and privacy.

There’s also potential for use of this technology in other areas beyond the health sector which makes it even more interesting.

“I’m very excited to see how our extensive partnership with Health Invest Finland is evolving. Based on mutual trust and transparency, Health Invest Finland and CellMark have created a business concept to secure supply of the My+Carehardware and a structure to provide service for customers worldwide. We believe that this agreement and future collaboration between our two companies is the way forward that will lead to sustainable business growth and improved patient outcomes in a world that is ageing fast ”, commented Niclas Möttus Olsson, President CellMark Medical.

Read Health Invest’s full announcement here. 




Share this article